Shares of Milestone Scientific Inc. (NYSE:MLSS – Get Free Report) rose 0.9% on Wednesday . The stock traded as high as $1.20 and last traded at $1.17. Approximately 57,443 shares were traded during mid-day trading, a decline of 72% from the average daily volume of 202,214 shares. The stock had previously closed at $1.16.
Analyst Upgrades and Downgrades
MLSS has been the subject of several research reports. StockNews.com initiated coverage on Milestone Scientific in a report on Wednesday, January 29th. They issued a “hold” rating for the company. Benchmark reiterated a “speculative buy” rating and issued a $1.25 target price on shares of Milestone Scientific in a report on Wednesday, November 20th.
View Our Latest Stock Analysis on MLSS
Milestone Scientific Stock Performance
Institutional Investors Weigh In On Milestone Scientific
A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Carnegie Investment Counsel increased its holdings in shares of Milestone Scientific by 18.9% in the fourth quarter. Carnegie Investment Counsel now owns 172,609 shares of the company’s stock valued at $166,000 after purchasing an additional 27,412 shares during the period. Geode Capital Management LLC increased its holdings in shares of Milestone Scientific by 6.4% in the third quarter. Geode Capital Management LLC now owns 527,005 shares of the company’s stock valued at $480,000 after purchasing an additional 31,572 shares during the period. Y Intercept Hong Kong Ltd acquired a new position in shares of Milestone Scientific in the third quarter valued at about $48,000. Renaissance Technologies LLC increased its holdings in shares of Milestone Scientific by 72.8% in the fourth quarter. Renaissance Technologies LLC now owns 126,275 shares of the company’s stock valued at $121,000 after purchasing an additional 53,198 shares during the period. Finally, World Investment Advisors LLC acquired a new position in shares of Milestone Scientific in the third quarter valued at about $91,000. 5.79% of the stock is currently owned by hedge funds and other institutional investors.
About Milestone Scientific
Milestone Scientific Inc, a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments.
See Also
- Five stocks we like better than Milestone Scientific
- When to Sell a Stock for Profit or Loss
- Nebius Group: NVIDIA’s Investment Sparks All-Time Highs
- Trading Stocks: RSI and Why it’s Useful
- SoFi Stock Rallying Strong in the Last 5 Days—What’s Driving It?
- How Investors Can Identify and Successfully Trade Gap-Down Stocks
- Intel Surges on M&A Talks: Rally Beginning or Just a Headfake?
Receive News & Ratings for Milestone Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Milestone Scientific and related companies with MarketBeat.com's FREE daily email newsletter.